Gene · 10460
Papers1,759
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,759
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Spatial Multiomics Defines a Shared Tumor Infiltrative Signature at the Resection Margin in High-Grade Gliomas. | Cancer Res | 2025 | 40759029 | PubTator, text mining | PubMed |
| Epigenetic regulation of cancer stemness. | Signal Transduct Target Ther | 2025 | 40744921 | PubTator, text mining | PubMed |
| A diverse landscape of FGFR alterations and co-mutations suggests potential therapeutic strategies in pediatric low-grade gliomas. | Nat Commun | 2025 | 40744913 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR Axis in Cancer: From Pathogenesis to Treatment. | MedComm (2020) | 2025 | 40740483 | PubTator, text mining | PubMed |
| The complex role and molecular mechanism of family with sequence similarity genes in cancer: a comprehensive review. | Discov Oncol | 2025 | 40736938 | PubTator, text mining | PubMed |
| Proteome of oocyte spindle identifies Ccdc69 regulates spindle assembly like "band-tightening spell". | Cell Mol Life Sci | 2025 | 40736675 | PubTator, text mining | PubMed |
| Correction: FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway. | Front Oncol | 2025 | 40672757 | PubTator, text mining | PubMed |
| FGFR inhibitors promote the autophagic degradation of IFN-γ-induced PD-L1 and alleviate the PD-L1-mediated transcriptional suppression of FGFR3-TACC3 in non-muscle-invasive bladder cancer. | Cell Death Dis | 2025 | 40603902 | PubTator, text mining | PubMed |
| Mechanistic Design of Cell-Penetrating Disruptors for a Phospho-Dependent Interaction. | Res Sq | 2025 | 40585227 | PubTator, text mining | PubMed |
| LC-MF-4, a Novel FGFR3 Degrader for Therapeutic Intervention in FGFR3-Altered Cancers. | J Med Chem | 2025 | 40575843 | PubTator, text mining | PubMed |
| Special Issue: Abstracts of the 11th Congress of the European Academy of Neurology, Helsinki, Finland. | Eur J Neurol | 2025 | 40542572 | PubTator, text mining | PubMed |
| CONTEXT-DEPENDENT VARIABILITY OF HIF HETERODIMERS INFLUENCES INTERACTIONS WITH MACROMOLECULAR AND SMALL MOLECULE PARTNERS. | bioRxiv | 2025 | 40502054 | PubTator, text mining | PubMed |
| Diffuse glioma with FGFR3::TACC3 gene fusion and prominent calcification: A case report. | Radiol Case Rep | 2025 | 40417325 | PubTator, text mining | PubMed |
| Radiotherapy-induced TACC3 confers resistance of HCC to radiotherapy and enhances IL4-dependent immunosuppression to exacerbate hepatocarcinogenesis. | Cancer Lett | 2025 | 40412795 | PubTator, text mining | PubMed |
| Human Papillomavirus Integration Induces Oncogenic Host Gene Fusions in Oropharyngeal Cancers. | Cancer Discov | 2025 | 40358390 | PubTator, text mining | PubMed |
| Potential biomarkers of primary resistance to first- and second-generation EGFR-TKIs in non-small-cell lung cancer: a real-world study. | Ther Adv Med Oncol | 2025 | 40322729 | PubTator, text mining | PubMed |
| Molecular characterization of FGFR fusion in a large real-world population and clinical utility of bidirectional fusion. | Chin Med J (Engl) | 2025 | 40293725 | PubTator, text mining | PubMed |
| FGFR3-TACC3 fusion gene promotes glioblastoma malignant progression through the activation of STAT3 signaling pathway. | Front Oncol | 2025 | 40265014 | PubTator, text mining | PubMed |
| TACC3 enhances glycolysis in bladder cancer cells through inducing acetylation of c-Myc. | Cell Death Dis | 2025 | 40246827 | PubTator, text mining | PubMed |
| The landscape of FGFR-TACC fusion in adult glioblastoma: From bench to bedside. | Mutat Res Rev Mutat Res | 2025 | 40246063 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10460/papers?page=4